Engineered CRISPR Nanoparticles Disrupt Tumor Adenosine to Boost Chemotherapy in Mice
Scientists engineered tumor-homing nanoparticles that co-deliver CRISPR gene editors and doxorubicin to permanently disable CD73, reversing adenosine-driven immunosuppression and shrinking ...










